Clinical progression of patients with COVID-19 in Shanghai, China

被引:501
作者
Chen, Jun [1 ]
Qi, Tangkai [1 ]
Liu, Li [1 ]
Ling, Yun [2 ]
Qian, Zhiping [3 ]
Li, Tao [4 ]
Li, Feng [5 ]
Xu, Qingnian [6 ]
Zhang, Yuyi [3 ]
Xu, Shuibao [1 ]
Song, Zhigang [7 ]
Zeng, Yigang [8 ]
Shen, Yinzhong [1 ]
Shi, Yuxin [9 ]
Zhu, Tongyu [8 ]
Lu, Hongzhou [2 ]
机构
[1] Shanghai Publ Hlth Clin Ctr, Dept Infect Dis & Immunol, Shanghai 201508, Peoples R China
[2] Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, 2901 Caolang Rd, Shanghai 201508, Peoples R China
[3] Shanghai Publ Hlth Clin Ctr, Dept Liver Intens Care Unit, Shanghai 201508, Peoples R China
[4] Shanghai Publ Hlth Clin Ctr, Dept TB, Shanghai 201508, Peoples R China
[5] Shanghai Publ Hlth Clin Ctr, Dept Resp Dis, Shanghai 201508, Peoples R China
[6] Shanghai Publ Hlth Clin Ctr, Dept Tradit Chinese Med, Shanghai 201508, Peoples R China
[7] Shanghai Publ Hlth Clin Ctr, Dept Pathogen Diag & Biosafety, Shanghai 201508, Peoples R China
[8] Shanghai Publ Hlth Clin Ctr, Dept Urol, 2901 Caolang Rd, Shanghai 201508, Peoples R China
[9] Shanghai Publ Hlth Clin Ctr, Dept Radiol, Shanghai 201508, Peoples R China
关键词
COVID-19; SARS-CoV-2; Clinical progression; Viral clearance; Clinical characteristics; SARS;
D O I
10.1016/j.jinf.2020.03.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Studies on the 2019 novel coronavirus disease (COVID-19) have generally been limited to the description of the epidemiology and initial clinical characteristics. We investigated the temporal progression in patients with COVID-19. Methods: In this retrospective, single-center study, we included confirmed cases of COVID-19 from Jan 20 to Feb 6, 2020 in Shanghai. Final date of follow-up was February 25, 2020. Results: Of the 249 patients enrolled, the median age was 51 years old, and 126 (50.6%) were male. The duration from onset of symptoms to hospitalization was 4(2-7) days in symptomatic patients. Fever was occurred in 235(94.3%) patients. A total of 215 (86.3%) patients had been discharged after 16(12-20) days hospitalization. The estimated median duration of fever in all the patients with fever was 10 days (95 confidential intervals [CIs]: 8-11 days) after onset of symptoms. Patients who were transferred to intensive care units (ICU) had significantly longer duration of fever as compared to those not in ICU (31 days v.s. 9 days after onset of symptoms, respectively, P <0.0001). Radiological aggravation of initial image was observed in 163 (65.7%) patients on day 7 after onset of symptoms. 154(94.5%) of these patients showed radiological improvement on day 14. The median duration to negative reverse-transcriptase PCR tests of upper respiratory tract samples was 11 days (95 CIs: 10-12 days). Viral clearance was more likely to be delayed in patients in ICU than those not in ICU (P <0.0001). In multivariate logistical analysis, age (Odds ratio [OR] = 1.06) and CD4 T cell count (OR = 0.55 per 100 cells/ul increase) were independently associated with ICU admission. Conclusions: The majority of COVID-19 cases are mild. The clinical progression pattern suggests that early control of viral replication and application of host-directed therapy in later stage is essential to improve the prognosis of CVOID-19. (C) 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E1 / E6
页数:6
相关论文
共 26 条
[1]  
[Anonymous], JAMA
[2]  
[Anonymous], Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected
[3]  
[Anonymous], 2020, LANCET
[4]  
[Anonymous], 2020, LANCET
[5]  
[Anonymous], NEW ENGL J MED
[6]  
[Anonymous], 2020, 40 WHO
[7]  
[Anonymous], NEW ENGL J MED
[8]  
[Anonymous], NEW ENGL J MED
[9]  
[Anonymous], NEW ENGL J MED 2020
[10]  
[Anonymous], 2020, LANCET